Author/Authors :
DYRHOVDEN, Gro S Norwegian Arthroplasty Register - Department of Orthopaedic Surgery - Haukeland University Hospital, Bergen , FENSTAD, Anne M Norwegian Arthroplasty Register - Department of Orthopaedic Surgery - Haukeland University Hospital, Bergen , FURNES, Ove Norwegian Arthroplasty Register - Department of Orthopaedic Surgery - Haukeland University Hospital, Bergen , GØTHESEN, Øystein Norwegian Arthroplasty Register - Department of Orthopaedic Surgery - Haukeland University Hospital, Bergen
Abstract :
Background and purpose — The long-term effects of computer-
assisted surgery in total knee replacement (CAS) compared to
conventionally operated knee replacement (CON) are still not
clear. We compared survivorship and relative risk of revision in
CAS and CON based on data from the Norwegian Arthroplasty
Register.
Patients and methods — We assessed primary total knee
replacements without patellar resurfacing reported to the Norwe-
gian Arthroplasty Register from 2005 through 2014. The 5 most
used implants and the 3 most common navigation systems were
included. The groups (CAS, n = 3,665; CON, n = 20,019) were
compared using a Cox regression analysis adjusted for age, sex,
ASA category, prosthesis brand, fi xation method, previous sur-
gery, and diagnosis with the risk of revision for any reason as end-
point. Secondary outcomes were reasons for revision and effects
of prosthesis brand, fi xation method, age (± 65 years), and hospi-
tal volume.
Results — Prosthesis survival and risk of revision were similar
for CAS and CON. CAS had signifi cantly fewer revisions due to
malalignment. Otherwise, no statistically signifi cant difference
was found between the groups in analyses of secondary outcomes.
Mean operating time was 13 minutes longer in CAS.
Interpretation — At 8 years of follow-up, CAS and CON had
similar rates of overall revision, but CAS had fewer revisions due
to malalignment. According to our fi ndings, the benefi ts of CAS at
medium-term follow-up are limited. Further research may iden-
tify subgroups that benefi t from CAS, and it should also empha-
size patient-reported outcomes.